Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Ozempic and the Risk of nAMD A recent article in JAMA Ophthamology (June 2025) suggests that vascular changes triggered by GLP-1 activity may trigger or worsen nAMD in some patients, especially those who are older, diabetic, or already at risk for macular degeneration
Thymosin 4 activates ILK and promotes cardiac cell migration, survival and repair
Cardiovasc Diabetol 19:85 Breder I, Cunha Breder J, Bonilha I, Munhoz DB, Medorima STK, Oliveira DC, do Carmo HR, Moreira C, Kontush A, Zimetti F, Zanotti I, Carvalho LSF, Nadruz W, Muscelli E, Quinaglia T, Sposito AC (2020) EXCEED-BHS3 Trial Investigator
Among these, oral GLP-1 drug development trends have emerged as a key focus, as the field shifts from injectable therapies to innovative oral treatments
But we don't have large, well-controlled human trials
